BROSHY ERAN
SEC insider (Form 3/4/5 filer). CIK 0001256230. Director at Certara, Inc. (CERT) and 1 other issuer. 12 reported Form 4/5 transactions since Sep 2024; latest on May 14, 2026. Located in RADNOR, PA.
Companies BROSHY ERAN has filed insider reports for
- Certara, Inc. (CERT): Director
- Theravance Biopharma, Inc. (TBPH): Director
BROSHY ERAN
CIK: 0001256230
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (12 total)
- May 14, 2026CERT
Certara, Inc.
AwardDirectRestricted Stock Units
33.2K shares- - May 14, 2026CERT
Certara, Inc.
ExerciseDirect15.8K shares- - Nov 26, 2025TBPH
Theravance Biopharma, Inc.
SaleDirect14K shares at avg. $20.00$280K - Nov 26, 2025TBPH
Theravance Biopharma, Inc.
ExerciseDirectShare Option (Right to Buy)
14K shares at avg. $10.15- - Nov 26, 2025TBPH
Theravance Biopharma, Inc.
SaleDirect15.5K shares at avg. $20.00$310K - Nov 11, 2025TBPH
Theravance Biopharma, Inc.
SaleDirect15.5K shares at avg. $17.00$264K - Nov 11, 2025TBPH
Theravance Biopharma, Inc.
SaleDirect14K shares at avg. $18.50$259K - Nov 11, 2025TBPH
Theravance Biopharma, Inc.
SaleDirect15.5K shares at avg. $18.50$287K - Nov 11, 2025TBPH
Theravance Biopharma, Inc.
ExerciseDirectShare Option (Right to Buy)
14K shares at avg. $10.15- - May 21, 2025CERT
Certara, Inc.
AwardDirectRestricted Stock Units
15.8K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| May 14, 2026 |  CERT Certara, Inc. | Award Restricted Stock Units | 33,222 | - | - | Direct |
| May 14, 2026 | CERT Certara, Inc. | Exercise | 15,757 | - | $0 | Direct |
| Nov 26, 2025 |  TBPH Theravance Biopharma, Inc. | Sale | 14,000 | $20.00 | $280,000 | Direct |
| Nov 26, 2025 | TBPH Theravance Biopharma, Inc. | Exercise Share Option (Right to Buy) | 14,000 | $10.15 | - | Direct |
| Nov 26, 2025 | TBPH Theravance Biopharma, Inc. | Sale | 15,501 | $20.00 | $310,020 | Direct |
| Nov 11, 2025 | TBPH Theravance Biopharma, Inc. | Sale | 15,500 | $17.00 | $263,500 | Direct |
| Nov 11, 2025 | TBPH Theravance Biopharma, Inc. | Sale | 14,000 | $18.50 | $259,000 | Direct |
| Nov 11, 2025 | TBPH Theravance Biopharma, Inc. | Sale | 15,500 | $18.50 | $286,750 | Direct |
| Nov 11, 2025 | TBPH Theravance Biopharma, Inc. | Exercise Share Option (Right to Buy) | 14,000 | $10.15 | - | Direct |
| May 21, 2025 | CERT Certara, Inc. | Award Restricted Stock Units | 15,757 | - | - | Direct |
1-10 of 12 transactions